Clinical image of sepsis-associated encephalopathy midst E. coli urosepsis: Emergency department database study
- PMID: 38655312
- PMCID: PMC11036046
- DOI: 10.1016/j.heliyon.2024.e29530
Clinical image of sepsis-associated encephalopathy midst E. coli urosepsis: Emergency department database study
Abstract
Background: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, which, if untreated, leads to multi-organ failure. One of the severe possible complications is sepsis associated encephalopathy (SAE), a neurological dysfunction occurring secondary to a severe inflammatory response. It manifests as acute cognitive dysfunction and sudden-onset dysfunctions in mental state. Uropathogenic Escherichia coli is the most common pathogen causing bacteremia, responsible for 80% of uncomplicated outpatient urinary tract infections and 40% of nosocomial infections. The study aimed to assess the difference in the severity and the course of urosepsis caused by E. coli in patients with and without septic encephalopathy.
Materials and methods: This study presents a retrospective analysis of the population of urosepsis patients admitted to the Emergency Department between September 2019 and June 2022. Inflammatory parameters, urinalysis and blood cultures were performed, along with a clinical evaluation of sepsis severity and encephalopathy. The patients were then stratified into SAE and non-SAE groups based on neurological manifestations and compared according to the collected data.
Results: A total of 199 septic patients were included in the study. E. coli-induced urosepsis was diagnosed in 84 patients. In this group, SAE was diagnosed in 31 (36.9%) patients (33.3% in males, 40.5% females). Patients with SAE were found to be hypotensive (p < 0,005), with a higher respiratory rate (p < 0,017) resulting in a higher mortality rate (p = 0.002) compared to non-SAE septic patients. The APACHE II score was an independent risk factor associated with a higher mortality rate. Biochemical parameters between the groups did not show any statistical importance related to the severity of urosepsis.
Conclusions: The severity of urosepsis and risk of SAE development increase according to the clinical condition and underlying comorbidities. Urosepsis patients with SAE are at a higher risk of death. Patients should undergo more careful screening for the presence of SAE on admission, and more intense monitoring and treatment should be provided for patients with SAE. This study indicates the need to develop projects aiming to further investigate neuroprotective interventions in sepsis.
Keywords: APACHE; Escherichia coli; Mental alteration; Sepsis associated encephalopathy; Urosepsis.
© 2024 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Michal Markuszewski reports financial support was provided by National Science Centre Poland. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Characterization of Sepsis and Sepsis-Associated Encephalopathy.J Intensive Care Med. 2019 Nov-Dec;34(11-12):938-945. doi: 10.1177/0885066617719750. Epub 2017 Jul 18. J Intensive Care Med. 2019. PMID: 28718340
-
A retrospective study of sepsis-associated encephalopathy: epidemiology, clinical features and adverse outcomes.BMC Emerg Med. 2020 Oct 6;20(1):77. doi: 10.1186/s12873-020-00374-3. BMC Emerg Med. 2020. PMID: 33023479 Free PMC article.
-
[Construction and analysis of early warning and prediction model for risk factors of sepsis-associated encephalopathy].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Feb;36(2):124-130. doi: 10.3760/cma.j.cn121430-20231008-00847. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38442925 Chinese.
-
Potential Neuroprotective Role of Melatonin in Sepsis-Associated Encephalopathy Due to Its Scavenging and Anti-Oxidative Properties.Antioxidants (Basel). 2023 Sep 21;12(9):1786. doi: 10.3390/antiox12091786. Antioxidants (Basel). 2023. PMID: 37760089 Free PMC article. Review.
-
Meta-analysis of evaluating neuron specific enolase as a serum biomarker for sepsis-associated encephalopathy.Int Immunopharmacol. 2024 Apr 20;131:111857. doi: 10.1016/j.intimp.2024.111857. Epub 2024 Mar 14. Int Immunopharmacol. 2024. PMID: 38489973
Cited by
-
Microbiological and clinical predictors of sepsis-associated encephalopathy in bloodstream infections: a retrospective cohort study.Front Cell Infect Microbiol. 2025 Mar 7;15:1548370. doi: 10.3389/fcimb.2025.1548370. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40125514 Free PMC article.
-
Gram-Negative Bacteremia With Atypical Neurologic Presentation Following Tattoo Application.Cureus. 2025 Apr 16;17(4):e82373. doi: 10.7759/cureus.82373. eCollection 2025 Apr. Cureus. 2025. PMID: 40385782 Free PMC article.
References
-
- Shankar-Hari M., Phillips G.S., Levy M.L., Seymour C.W., Liu V.X., Deutschman C.S., et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016 Feb 23;315(8):775–787. - PMC - PubMed
-
- Tauber S.C., Djukic M., Gossner J., Eiffert H., Brück W., Nau R. Sepsis-associated encephalopathy and septic encephalitis: an update. Expert Rev. Anti-infect. Ther. 2021;19(2):215–231. https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1812384 [Internet] Feb 1 [cited 2022 May 11] - DOI - PubMed
LinkOut - more resources
Full Text Sources